PT  - JOURNAL ARTICLE
AU  - Zhouxuan Li
AU  - Songyuan Tang
AU  - Shan Liu
AU  - Huan Xu
AU  - Zhen Lei
AU  - Ying Zhong
TI  - Effect of Female Age on Infertility Diagnostic Factors and In-vitro Fertilization Treatment Outcomes: A Single-center Retrospective Cohort Study
AID  - 10.1101/2021.01.04.21249246
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.04.21249246
4099  - http://medrxiv.org/content/early/2021/01/06/2021.01.04.21249246.short
4100  - http://medrxiv.org/content/early/2021/01/06/2021.01.04.21249246.full
AB  - Background Infertility has become an important issue in modern world because of the increasing number of infertile couples around the world. Advanced maternal age was considered to be a main factor of infertile problem. With second child policy published in China and more women in China intend to seek help for infertility problem, this study provided information of fertility diagnostic factors and IVF treatment outcomes of female IVF patients in different age groups, which can be a guidance for infertility diagnostic and treatment.Methods A retrospective cohort study was conducted to IVF patient data collected by Jinjiang District Maternal and Child Health Hospital, Chengdu, China. Clinical and laboratory data of 45,743 fresh, autologous IVF cycles from January 2008 to September 2017 were included in the analysis. The diagnostic factors and treatment outcomes were analyzed for different age groups (age<35, n=30,708; age 35-41, n=11,921 and age≥42, n=3,114) as well as further stratified advanced age groups (age 42, n=933; age 43, n=744; age 44, n=556; age≥45, n=881). The characteristics including number of previous cycles, duration of infertility, BMI, basic FSH, basic AFC, AMH, retrieved oocyte number, fertilized oocyte number, transferred embryo number, baby number and economic cost were stratified according to patient age.Results The basic characteristics of obesity rate, basic FSH and cancellation rate of IVF cycles in ≥42 years old group were significantly higher than other groups (p<0.01). Basic AFC, AMH, retrieved oocyte number, fertilized oocyte number and transferred embryo number in ≥42 years old group were significantly lower than other groups (p<0.01). Diagnostics characteristics and IVF-ET outcome declined significantly when maternal age increased (p<0.05). In the meanwhile, a preliminary analysis of cost per cycle showed that cost per child increased with patient’s age increase.Conclusion Although with increasing number of advanced maternal age IVF cycles, the age group of ≥42 years would intend to get unsatisfied outcome and higher cost per child. More guidance and considerations should be focused on encouraging earlier age treatment of infertility.Plain English summary With more and more women in the global range choose to get late pregnancy because of changes in society and economy, age has become an unavoidable factor in infertility diagnostic and treatment. Advanced age women may experience more infertility problems and negative IVF outcomes. A better understanding of the effect of maternal age on infertility would offer help to both diagnostic and treatment of IVF patient. This study conducted a single-center retrospective cohort analysis to female patients of different age groups and found that women with more advanced age (≥42) would be more easily to experience unsatisfied IVF outcome and higher economic cost to obtain one child. After the publication of second child policy in China in 2013, the number of advanced age patients increased, the necessity of special guidance for AMA patient may need to be taken into consideration.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Youth research project of Sichuan province medical association: Study on the outcome of IVF-ET (In-Vitro Fertilization-Embryo Transfer) pregnancy of female elderly patients and its influencing factors based on large sample size (Q17021).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethics committee of Jinjiang District Maternal and Child Health Hospital IVF center in Chengdu, China. has reviewed and approved this research.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.IVF-ETIn Vitro Fertilization and Embryo TransferARTAssisted Reproductive TechnologyAMAAdvanced Maternal AgeBMIBody Mass IndexHCGHuman Chorionic GonadotropinFSHFollicle Stimulating HormoneAFCAntral Follicle CountAMHAnti-Müllerian HormoneCOSControlled Ovarian Stimulation